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Abstract
A family of anion exchangers (AEs) including AE1, AE2 and AE3 has been described. AE3 gene has been shown to encode
two alternatively spliced isoforms termed as bAE3 (brain subtype) and cAE3 (cardiac subtype). The identity of the AE(s)
involved in the human intestinal NaCl absorption is not fully understood. Current studies were undertaken to identify the AE
isoforms expressed in the human intestine, to define their regional and vertical axis (crypt vs. surface cells) distribution, and
to elucidate their membrane localization in the epithelial cells along the entire length of the human intestine. Our studies
utilizing reverse transcription (RT)-PCR with total RNA extracted from pinch biopsies from various regions of the human
intestine demonstrate that AE2 and bAE3 but not AE1 or cAE3 were expressed in all the regions of the human intestine.
Utilizing in situ RT-PCR, we demonstrated that the message of AE2 was expressed throughout the vertical surface^crypt axis
of the colon. Our Western blotting studies demonstrated that AE2 and bAE3 are localized to the basolateral but not the
apical membranes of the intestinal epithelial cells from the human ileum and colon. In conclusion, our results demonstrated
that in the human intestine, AE2 and bAE3, but not AE1 or cAE3, are expressed throughout the tract with the highest
expression in the colon compared to the ileum and jejunum. Both the isoforms were found to be localized to the basolateral
but not the apical membranes of the epithelial cells. We speculate that, in the human intestine, AE2 and bAE3 may be the
‘housekeeping’ isoforms, and the apical AE, the potential candidate for chloride absorption, remains to be
identified. ß 2001 Elsevier Science B.V. All rights reserved.
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1. Introduction
The major mechanism of NaCl absorption in the
human intestine has been suggested to be through
the operation of dual ion exchangers of Na/H
and Cl3/HCO33 [1]. Sodium^hydrogen exchangers
(NHEs) and anion exchangers (AEs) are plasma
membrane proteins that mediate in eukaryotes the
electroneutral exchange of extracellular Na and
Cl3 with intracellular H and HCO33 , respectively,
with a stoichiometry of 1:1. These exchange activities
are nearly ubiquitous among vertebrate cells.
Although NHE isoforms and their involvement in
intestinal vectorial Na transport are currently under
intense investigation by many investigators including
our laboratory, the identity of the human intestinal
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AE isoforms and their role in the intestinal chloride
absorption has not been de¢ned.
AEs have been shown to contribute, in a cell-spe-
ci¢c manner, to the maintenance of intracellular pHi,
intracellular [Cl3], volume regulation, and vectorial
bicarbonate and chloride transport [2]. Recent stud-
ies have identi¢ed a family of at least three structur-
ally and functionally related genes for AE, termed as
AE1, AE2 and AE3 [2]. The cDNA and genes for
these isoforms have been cloned from di¡erent spe-
cies including human [2].
AE1 or band-3 AE in the erythrocytes was the ¢rst
described AE. Outside the erythrocytes the predom-
inant site of AE1 expression is the kidney, where
immunocytochemical localization studies have found
its polypeptide restricted to the basolateral mem-
brane of type-A acid secreting intercalated cells [2].
AE2 mRNAs are widely expressed in epithelial and
mesenchymal tissues [2]. Membrane localization
studies revealed that AE2 polypeptide was disposed
to the basolateral membranes of alveolar epithelial
cell monolayers in the rat [3], choroid plexus epithe-
lium [4], mouse small intestinal epithelium [5] and
gastric parietal cells in the human [6]. Previous stud-
ies, however, have revealed that membrane localiza-
tion of the AE2 isoform in the mammalian intestine
is controversial. For example, in the rabbit ileum,
Chow et al. demonstrated that AE2 was localized
to the apical membranes [7]. In contrast, Rossman
et al. showed that AE2 was localized to the baso-
lateral membranes of rabbit ileal enterocytes [8]. Of
the above three isoforms, AE3 gene has been shown
to code at least two transcripts and two protein iso-
forms, bAE3 (brain subtype) and cAE3 (cardiac sub-
type) which are believed to be alternatively spliced
products of the same gene. The two proteins di¡er in
their 42 amino acid residues at the N-terminal. Adult
hearts of rat, rabbit, chicken and human express
both bAE3 and cAE3 at roughly equal levels [9].
To date, very little is known about expression of
the AE3 isoforms in epithelial tissues.
Previous studies from our laboratory, utilizing or-
gan donor colonic apical and basolateral membrane
vesicles, have shown the presence of kinetically dis-
tinct Cl3/HCO33 exchange activities in the apical and
basolateral membranes of the human colon [10^12].
Therefore, the goals of the current studies were to
identify the AE isoforms expressed along the entire
length of the human intestine, to compare their rel-
ative abundance in various regions of the tract, to
characterize the apical vs. basolateral membrane lo-
calization and the vertical axis distribution of the
isoforms.
Our results demonstrated that: (i) AE2 and bAE3
isoform mRNAs were present along the entire length
of the human intestine, whereas AE1 and cAE3
mRNAs were not detected; (ii) AE2 mRNA was ex-
pressed along the entire vertical axis of the colonic
crypt including the surface cells; and (iii) the protein
products of AE2 and bAE3 were localized predom-
inantly to the basolateral but not the apical mem-
branes with a higher expression in the colon com-
pared to the ileum and jejunum.
2. Materials and methods
2.1. Isolation of RNA
Human tissue samples were either obtained from
pinch biopsies or surgically removed and immedi-
ately suspended in RNAzol solution for total RNA
extraction. Collection of these specimens was per-
formed according to approved protocols by the In-
stitutional Review Board of the University of Illinois
at Chicago and by the Human Investigations Sub-
committee of the West Side VA Medical Center. To-
tal RNA was extracted from various tissue sources
by the method of Chomczynski and Sacchi [13] using
RNAzol solution supplied by the manufacturer (Tel-
Test Inc., Friendswood, TX, USA) and essentially
using the manufacturer’s protocol.
2.2. Designing of PCR primer sets for AE1, AE2,
bAE3 and cAE3
The unique PCR primer sets for AE1, AE2, bAE3
and cAE3 were designed from the amino-terminal
regions (region exhibiting maximal diversity among
the isoforms) of the published human sequences uti-
lizing Gene Works software (Intelligenetics, Moun-
tain View, CA, USA). The primer sequences are giv-
en below: AE1: 5P-primer: 5P-CCAGACTCCAGC-
TTCTACAAGG-3P (position 1174^1195), 3P-primer:
5P-GGAAGGAGAAGATCTCCTGG-3P (position
1674^1693) (length of ampli¢ed region 520 residues,
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M27819) [14]; AE2: 5P-primer: 5P-GAAGATTCCT-
GAGAATGCCG-3P (position 1698^1717), 3P-prim-
er: 5P-GTCCATGTTGGCACTACTCG-3P (position
1859^1878) (length of ampli¢ed region 181 residues,
U62531) [15]; AE3: 5P-primer: 5P-GTCCTCATCCT-
GATCTTCATGG-3P (position 2997^3018), 3P-prim-
er: 5P-GGACAGCTGGATACCAGAC-3P (position
3377^3395) (length of ampli¢ed region 399 residues,
U05596) [9] ; bAE3: 5P-primer: 5P-ATCTGAGGCA-
GAACCTGTGG-3P (position 452^471), 3P-primer:
5P-TTTCACTAAGTGTCGCCGC-3P (position 851^
869) (length of ampli¢ed region 418 residues,
U05596) [9] ; cAE3: 5P-primer: 5P-TTTGAG-
GATGGTGACCTGTG-3P (position 260^279), 3P-
primer: 5P-CTTGTCATCGTTGGGATGG-3P (posi-
tion 793^811) (length of ampli¢ed region 551 resi-
dues, U05597) [9].
2.3. Reverse transcription (RT)-PCR technique
RT-PCR was performed essentially as described
[16]. Brie£y, 2^4 Wg of total RNA was used for RT
with sequence-speci¢c primers and SuperScript II re-
verse transcriptase (Gibco BRL, Gaithersburg, MD,
USA). The reaction was carried out in a 20 Wl reac-
tion containing 100 mM Tris^HCl pH 8.3, 2.5 mM
MgCl2, 10 mM dithiothreitol (DTT), 50 mM KCl,
1 WM dNTPs, 10 WM of antisense primer, 1 Wl of
SuperScript II reverse transcriptase and incubated
at 42‡C for 1 h. The reaction was terminated by
heating at 70‡C for 15 min, then 1 Wl of RNase H
was added to the reaction and incubated for 20 min
at 37‡C.
Two Wl of the RT reaction was diluted into a ¢nal
volume of 50 Wl of a PCR mix containing 100 mM
Tris^HCl (pH 8.3), 2.5 mM MgCl2, 50 mM KCl, 200
WM dNTPs, 1 WM of each antisense and sense prim-
ers, 0.5 Wl of a mix of Taq DNA polymerase (Gibco
BRL, Gaithersburg, MD, USA) and Taq Pfu (Stra-
tagene, La Jolla, CA, USA) with the ratio of 16:1
(unit/unit). PCR reaction was carried out using a
Microcycler programmable heating/cooling dry block
(Perkin Elmer Corp., Norfolk, CT, USA) for 30^40
cycles of ampli¢cation (94‡C, 30 s; 55‡C, 1 min;
72‡C, 30 s) followed by 10 min at 72‡C. PCR prod-
ucts were separated by electrophoresis on a 1% aga-
rose gel containing ethidium bromide (0.5 Wg/ml).
Bands of expected sizes were visualized under UV
light utilizing Eagle eye II Still Video System (Stra-
tagene, La Jolla, CA, USA).
2.4. In situ RT-PCR
This technique was performed as described by
Nuovo [17] with minor modi¢cations which have
been standardized in our laboratory for the expres-
sion of AE isoforms in the intestinal tissues. Brie£y,
tissues ¢xed in formalin and stored in para⁄n blocks
were carefully selected to include speci¢c regions of
the human intestine. Slides with tissue sections V5
Wm thick were initially depara⁄nized by three xylene
washes, 2 min each, hydrated with graded ethanol
and treated with pepsin (2 mg/ml+0.1 N HCl) for
15^30 min at 37‡C in a moist chamber. Tissue sec-
tions were washed with DEPC water and then with
100% ethanol for 1 min each, and treated with
RNase-free DNase at 37‡C overnight in a moist
chamber. RT reaction on the tissue section was per-
formed utilizing gene-speci¢c primers and RT reac-
tion mixture (containing 100 mM Tris^HCl pH 8.3,
50 mM KCl, 5 mM MgCl2, 1 mM dNTPs, 10 WM
antisense primer, 2 U/Wl of RNasin (Promega, Mad-
ison, WI, USA) and 5 U/Wl of SuperScript II reverse
transcriptase) in a total volume of 40 Wl at 42‡C in a
moist chamber for 1 h. The tissue sections were then
washed again with DEPC water and 100% ethanol.
The cDNA is then ampli¢ed in situ by direct incor-
poration of the digoxigenin-dUTP (Boehringer-
Mannheim, Indianapolis, IN, USA), in the ampli¢ed
product, in 100 Wl of a PCR reaction mix (containing
100 mM Tris^HCl pH 8.3, 50 mM KCl, 4.5 mM
MgCl2, 200 WM dNTPs, 10 WM of digoxigenin-
dUTP, 1 WM of each primer, 8 U/100 Wl Taq Pfu
polymerase, 10% glycerol, 3 mg/ml bovine serum al-
bumin) on the tissue sections and incorporating the
reporter molecule, digoxigenin-dUTP (Boehringer-
Mannheim, Indianapolis, IN, USA), directly in the
ampli¢ed DNA. The PCR mixture is sealed on the
tissue sections with a coverslip utilizing Gene-Frames
(Marsh Biomedical, Rochester, NY, USA). The
sealed slides with PCR mix on the tissue sections
are immediately returned on a robocycler (Strata-
gene, La Jolla, CA, USA), heated to 96‡C for
5 min, then the PCR reaction is carried out by 40
cycles of: 96‡C for 1 min, 55‡C for 2 min, 74‡C for
50 s, followed by 7 min at 74‡C. The slides are then
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washed in phosphate-bu¡ered saline (PBS) (pH 7.4)
bu¡er and dehydrated with graded ethanol, then in-
cubated with anti-digoxigenin antibody (Boehringer-
Mannheim, Indianapolis, IN, USA) conjugated with
alkaline phosphatase for 60 min at 37‡C in a moist
chamber then washed with PBS followed by staining
with NBT/BCIP (Boehringer-Mannheim, Indianapo-
lis, IN, USA) at 37‡C for 10^15 min. Slides are then
washed with PBS, dehydrated with graded ethanol
and counterstained with BC-50 Red counterstain
(Biomeda, Foster city, CA, USA). The tissue sec-
tions are mounted by situ mount (Biomeda, Foster
city, CA, USA) and visualized under a microscope.
Appropriate negative (omit RT step) and positive
control (omit DNase treatment step) tissue slides
are processed simultaneously to ensure the speci¢city
of the PCR products synthesized. Adjacent tissue
sections from the same tissue block are stained
with HpE stain to identify speci¢c cell types matched
to the stained cells by the in situ RT-PCR meth-
ods.
2.5. Isolation of human intestinal apical and
basolateral membrane vesicles
Human intestinal apical (brush-border) and baso-
lateral membranes from the small intestine and colon
were prepared as described [18^22], starting with a
scraped mucosa from various regions of the intestine
procured from organ donors provided by ROBI
(Regional Organ Bank of Illinois, Chicago, IL,
USA). The ¢nal pellet of the membrane vesicles
was resuspended in PBS bu¡er containing protease
inhibitors: 50 WM phenylmethylsulfonyl £uoride,
1 Wg/ml leupeptin, 1 Wg/ml pepstatin, 1 Wg/ml trypsin
inhibitors, and 1 Wg/ml chymostatin. The membranes
were frozen for later analysis by immunoblotting.
These investigations were approved by the Human
Investigation Committee of the West Side VA Med-
ical Center and the Institutional Review Board of the
University of Illinois at Chicago.
2.6. Antibodies
The AE2 antibodies were raised against an 11 ami-
no acid peptide representing amino acid residues
1230^1240 of the C-terminal end of human AE2
(VDEYNEMPMPV). For AE3 they were raised
against a 12 amino acid peptide representing amino
acids 1221^1232 of the C-terminal end of human
bAE3, brain subtype of AE3 (GQDEYNELHMPV).
Brie£y, the peptides were commercially synthesized
by Bio-Synthesis Inc., Lewisville, TX, USA, then
conjugated to an adjuvant and injected into two rab-
bits for each antibody. Enzyme-linked immunosorb-
ent assay testing was done on the immunized serum.
The immune serum was passed over a column of
activated beads which were covalently coupled to
puri¢ed anti-immunoglobulin antibodies. The beads
were washed and the antibodies were eluted by treat-
ing the column with a low pH bu¡er and then a high
pH bu¡er (Bio-Synthesis Inc., Lewisville, TX, USA).
These a⁄nity-puri¢ed polyclonal antibodies were
used as immunologic probes for immunoblotting
studies.
2.7. Immunoblotting
150 Wg each of puri¢ed brush-border and basolat-
eral membranes were solubilized in Laemmli sample
bu¡er (2% sodium dodecyl sulfate (SDS), 100 mM
DTT, 60 mM Tris, pH 6.8, 0.01% bromophenol blue)
and separated on 6% Tris^glycine SDS^polyacryl-
amide gel by the methods of Laemmli. Brush-border
and basolateral membrane proteins from the same
region and the same organ donor were separated
on the same gel along with high range molecular
weight protein standards (Amersham, Arlington
Heights, IL, USA). The separated proteins were
then electrotransferred onto nitrocellulose mem-
branes (Bio-Rad Laboratories, Hercules, CA, USA)
and visualized with Ponceau stain to ensure the e⁄-
ciency of the transfer. Immunoblotting was per-
formed by washing the nitrocellulose membranes
three times, then blocking them for 1 h in Blotto
solution containing 5% non-fat dry milk in PBS
(150 mM NaCl, 10 mM Na-phosphate, 2 mM
EDTA, 2% NP 40). The blots were then incubated
with the primary antibodies diluted in the blocking
solution for 1 h at room temperature, and washed
extensively after that with the same solution. The
blots were subsequently incubated for 1 h at room
temperature with horseradish peroxidase-conjugated
goat anti-rabbit secondary antibodies (diluted
1:2000) in solution containing 1% non-fat dry milk
in PBS. Blots were again washed extensively with the
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same solution. The bands were visualized by
enhanced chemiluminescence according to the
manufacturer’s instructions (Amersham, Arlington
Heights, IL, USA).
3. Results
3.1. Detection of AE isoforms expressed in the human
intestine
To identify the isoforms of AE gene family ex-
pressed in the human intestine, we performed RT-
PCR on total RNA extracted from pinch biopsy
samples obtained endoscopically from di¡erent re-
gions of the human intestine. Gene-speci¢c primers
for AE1, AE2, bAE3 and cAE3 were designed from
the amino-terminal regions of the exchangers which
di¡er between the isoforms (see Section 2). As shown
in Fig. 1, the AE2 transcript of an expected size of
181 bp is detected in the human ascending, trans-
verse, sigmoid, and descending colon. AE2 mRNA
was also detected in ileum, jejunum and esophagus
(not shown). In controls, i.e. in the absence of the
RT enzyme, the AE2 PCR products were not syn-
thesized.
Utilizing gene-speci¢c primers (see Section 2), the
PCR product of an expected size of 520 bp for AE1
could not be detected in any of the regions of intes-
tine tested. However, under the same conditions we
were able to detect the same expected size band in
the human kidney RNA (positive control) ensuring
that the lack of detection of AE1 in the human in-
testine was not due to technical reasons.
RT-PCR with AE3 gene-speci¢c primers showed
(Fig. 2) that products with the expected size of 399
bp were detected in the jejunum, ileum, ascending,
transverse, descending, sigmoid colon, and rectum.
To elucidate whether bAE3 or cAE3 subtypes were
expressed, another set of primers was designed from
the variant N-terminal region of the two subtype iso-
forms, and RT-PCR with these primers was per-
formed again on total RNA from various regions
of the human intestine along with control total
RNA for human brain and cardiac tissues. As shown
in Fig. 3, the expected PCR products for bAE3 with
the size of 418 bp were detected in all human intes-
tinal regions and the brain (used as positive control),
whereas cAE3 PCR product (expected size of 551 bp)
was only detected with the cardiac RNA (positive
control) but not in any region of the human intes-
tine.
Representative PCR fragments (from the descend-
ing colon) with the expected size for AE2 and bAE3
were subcloned in PCRII vector utilizing TA cloning
kit (In Vitrogen, San Diego, CA, USA) and se-
quenced to con¢rm the identity of the AE tran-
scripts. The sequences were 100% identical to the
respective published AE sequences [9,23] (not
shown).
Fig. 1. RT-PCR analysis of AE2 message in the human intes-
tine. Lane A: DNA ladder 123, lane B: ascending colon, lane
C: transverse colon, lane D: sigmoid colon, lane E: descending
colon.
Fig. 2. RT-PCR analysis of AE3 in the human intestine. Lanes A and I represent DNA ladder 123, lanes B, C, D, E, F, G and H
represent jejunum, ileum, ascending colon, transverse colon, descending colon, sigmoid colon and rectum, respectively.
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3.2. Cellular and vertical axis distribution of
AE2 transcripts in human intestine
To further analyze the cellular and vertical axis
distribution of AE2 mRNA in the colon, in situ
RT-PCR was performed utilizing gene-speci¢c PCR
primers for AE2. Formalin-¢xed para⁄n-embedded
archival tissue sections from the colon were treated
as described in Section 2. Results are represented in
Fig. 4 (left panel), which shows human colonic (de-
Fig. 3. RT-PCR analysis for bAE3 and cAE3 isoforms in the human colon. Lane B: brain control, lanes C, D, E, F, G represent
bAE3 message (size 418 bp) in ascending, transverse, descending, sigmoid colon and rectum, respectively. Lane H represents cardiac
control, lanes I^M represent the same colonic regions where no cAE3 message was detected (size 551 bp) compared to the control.
Lanes A, N represent DNA ladder (123).
Fig. 4. In situ RT-PCR analysis of AE2 mRNA in descending human colon. A: The cytoplasmic blue signal represents AE2 mRNA
which can be seen only in the epithelial cells in the crypt and the surface cells. B: Represents the positive control without DNase di-
gestion where the signal is detected in all cell types and mostly in the nuclei. C: Represents the negative control where the RT enzyme
was omitted, and no signal can be detected.
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scending colon) sections, and Fig. 4 (middle and
right panels) which represent the positive and the
negative controls, in which the DNase step and the
RT enzyme were omitted, respectively. The blue
cytoplasmic signal which represents AE2 mRNA is
observed in all epithelial cell types including the
crypt and the surface cells but not in the submucosal
regions. The signal in the positive control is noticed
in all cell types (epithelial and subepithelial cells) and
mostly from the nuclei (representing signal from ge-
nomic DNA), whereas no signal was detected in the
negative control indicating the speci¢city of the prim-
ers and the reliability of our results.
3.3. Membrane localization of AE2 and bAE3
To determine whether AE2 and bAE3 are apical
or basolateral isoforms, we analyzed isolated puri-
¢ed apical and basolateral membranes from dif-
ferent regions of the human intestine by immuno-
blotting.
Antibodies, raised against peptides representing
the C-terminal fragment of AE2 and bAE3 as de-
scribed before (see Section 2), were used as immuno-
logic probes. As shown in Fig. 5, the AE2 antibodies
(1:5000 dilution, 1 h incubation with blot at 25‡C)
detected a band with the expected relative size of
V170 kDa predominantly in the basolateral mem-
branes of both the proximal and distal colonic re-
gions. As shown in the left panel, incubation of the
AE2 antibody with the blot in the presence of free
peptide (10 Wg/ml) signi¢cantly competed out the
AE2 band signal. Furthermore, as shown in the right
panel, preimmune sera showed no signal of the ex-
pected size band, con¢rming the speci¢city of our
Fig. 5. Immunoblotting for AE2 in the colon. Bands with the
expected size V170 kDa predominantly in the basolateral
(BLM) but not the apical (AMV) membranes in both proximal
and distal colon are detected. The band signal is competed out
signi¢cantly with the free peptide (left panel), and the preim-
mune sera showed no signal of expected size band (right panel).
Fig. 6. Immunoblotting for AE2 in the small intestine. The ex-
pected size bands V170 kDa in the BLM of the ileum and
jejunum from two di¡erent organ donors 1 and 2, after over-
night incubation with the antibody at 4‡C.
Fig. 7. Immunoblotting for bAE3 in the colon. The bands (size
V165 kDa) are shown predominantly in the basolateral but
not the apical membrane, in both the proximal and distal co-
lon.
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antipeptide antibodies. Peptide competition and neg-
ative staining with the preimmune serum were the
same in all the intestinal regions tested (not shown).
A faint band of the expected size can also be detected
in the human distal colonic apical membranes as
well. In the ileum and jejunum, the basolateral
band of AE2 could only be detected after overnight
incubation of the 1:100 dilution of the primary
antibodies, as shown in Fig. 6, which represents ba-
solateral membranes from two separate organ do-
nors. The apical membranes from the jejunum and
ileum showed no cross reactivity with these antibod-
ies (data not shown).
Similar to AE2, bAE3 antibodies (1:5000 dilution,
1 h incubation at 25‡C) also detected the expected
band of aboutV165 kDa, predominantly only in the
basolateral and not the apical membranes in both the
proximal and distal colonic regions (Fig. 7). As
shown in Fig. 8, bAE3 antibodies (1:1000 dilution,
1 h incubation at 25‡C) detected the expected band
of V165 kDa only on the basolateral and not on the
apical membranes in the ileum. In the jejunal re-
gions, the expected size band was not detected. In-
cubation with the secondary antibodies alone did not
show bands of the expected sizes. Bands with the
approximately molecular weight of V50^80 kDa
were also detected when the primary antibodies
were used, but not with the preimmune serum or
the secondary antibodies alone. Most likely these
bands represent degradation products of the native
polypeptides.
4. Discussion
Utilizing puri¢ed apical membrane vesicles, we
have previously demonstrated the presence of apical
membrane Cl3/HCO33 exchange activity in ileal,
proximal and distal colonic regions of the human
intestine [10,11,24]. We have also recently demon-
strated the presence of kinetically distinct Cl3/
HCO33 exchange activity in the basolateral mem-
branes of the human colon [12]. However, the pro-
teins that mediate this transport remain largely un-
identi¢ed. In the present study, we demonstrate for
the ¢rst time the detection of the AE isoforms ex-
pressed in the human intestine and the cellular local-
ization of their polypeptides in the epithelial cells.
We have shown that AE2 and bAE3, not AE1 and
cAE3, mRNAs were detected along the entire length
of the human intestine. Furthermore, we showed that
AE2 mRNA was expressed in all epithelial cell types,
including surface cells along the entire vertical axis of
the colonic crypt. Our localization studies demon-
strated that AE2 and bAE3 polypeptides are local-
ized to the basolateral but not the apical membranes
of the epithelial cells.
Red cell band-3 AE1, the best characterized AE, is
the prototype member of the AE gene family. Studies
have shown that its predominant expression except
for the erythrocytes is in the kidney [2]. Rajendran et
al. have recently shown that AE1 is also expressed in
the rat colon [25]. Our current studies, however,
demonstrated that AE1 is not expressed in any re-
gion along the entire length of the human intestine.
These disagreements in AE isoform expression could
possibly be due to species di¡erences.
The AE3 gene has been shown to encode two dif-
ferent AE3 subtypes (brain and cardiac) which are
believed to be alternatively spliced transcripts. bAE3
(brain subtype) isoform has been cloned from the
brain tissues [26], whereas cAE3 (cardiac subtype)
and bAE3 have been cloned from the human heart
tissues [9]. However, very little is known about
the expression of AE3 in the intestinal epithelia. In
Fig. 8. Immunoblotting for bAE3 in the small intestine. The ex-
pected size (V165 kDa) is seen in the basolateral (BLM) but
not in the apical membranes (AMV) in the ileum but no ex-
pected size bands are seen in the jejunum. No cross reactivity
with the preimmune sera is observed.
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our current studies we have found that bAE3 but
not cAE3 message was detected in the human intes-
tine.
AE2 isoform is generally considered to be the ep-
ithelial isoform, however, studies from a number of
laboratories have detected its mRNA in a variety of
other non-epithelial tissues as well [2]. In earlier stud-
ies of Chow et al., the cDNA of AE2 was cloned
from the enterocytes of the rabbit ileum, and their
immunoblotting studies showed that AE2 was local-
ized to brush-border membranes and might be re-
sponsible for mediating the chloride absorption by
the enterocytes [7]. The full length cDNA of the hu-
man intestinal AE2 was obtained in our laboratory
from human colonic T84 cells, and it showed 100%
homology with the human kidney AE2 (data not
shown). Consistent with these results, our current
studies, utilizing the RT-PCR technique with gene-
speci¢c primers, showed that AE2 is expressed
throughout the human intestine. The results of our
current study in the human intestine regarding the
surface^crypt axis distribution of AE2 mRNA indi-
cated that the message for AE2 in the human colon
was also restricted to the surface and crypt epithelial
cells. However, no quantitative inferences could be
drawn utilizing this technique.
Most of the localization studies of the AE2 iso-
form have shown that this polypeptide was restricted
to the basolateral membranes of polarized epithelial
cells including rat colon, mouse small intestine and
kidney tubule cells [2,5,27,28]. However, Chow et al.
have shown by immunoblotting that AE2 was local-
ized to the apical membranes of the rabbit ileal enter-
ocytes, using polyclonal antibodies generated against
a fusion protein with the cytoplasmic fragment of the
cloned AE2 [7]. In contrast, Rossman et al., by using
antipeptide antibodies, have shown that AE2 was
localized to the basolateral and not the apical mem-
branes of the rabbit ileal enterocytes [8]. In the
present study, the antibodies were raised against
the same peptides which have previously been used
[8,9] representing the C-terminal of AE2 and bAE3.
Additionally, it has previously been shown [9] that
these antibodies were highly speci¢c as AE2 antipep-
tide antibodies did not detect bAE3 in transiently
transfected CHOP cell and bAE3 antipeptide anti-
bodies did not detect rat choroid plexus AE2. Utiliz-
ing these antibodies for immunoblotting, our results,
in agreement with the previous AE2 localization
studies [3^6], showed that AE2 is localized to the
basolateral membranes of the human intestinal epi-
thelial cells. Moreover, we also demonstrated here,
for the ¢rst time, that bAE3 polypeptides were also
localized to the basolateral but not the apical mem-
branes of the human colon and ileum. In the jeju-
num, the bAE3 protein was not detected. The expres-
sion of AE2 and bAE3 polypeptides was signi¢cantly
higher in the colon compared to the small intestine.
Additionally, previous studies from our laboratories
have shown a 6-fold higher Vmax value for chloride
uptake by the brush-border membrane Cl3/HCO33
exchange in the ileum compared to the proximal
and distal colon. The di¡erence in the Vmax values
for the apical chloride uptake along with the di¡er-
ences in the relative abundance of the AE2 and
bAE3 proteins in the distal versus proximal segments
of the human intestine, may further indicate that the
AE2 and bAE3 are probably not the isoforms which
are responsible for apical membrane Cl3/HCO33 ex-
change activity. In immunoblotting studies, faint
bands with expected sizes (V165^170 kDa) for
AE2 and bAE3 were also detected with the apical
membranes of the distal colon as well. This faint
expression can be explained by a possible cross con-
tamination of the apical membranes with basolateral
membranes, since the membranes from the proximal
colon tend to demonstrate slightly higher fold puri-
¢cation of the apical membrane marker (cysteine-
sensitive alkaline phosphatase assay) compared to
their counterparts from the distal colon (unpublished
results).
Our current results that AE2 and bAE3 are local-
ized to the basolateral membranes raise the question
about the identity of the protein that is responsible
for Cl3/HCO33 (OH
3) exchange process in the apical
membrane of the human intestinal cells. In this re-
gard, a series of recent studies have demonstrated
that DRA (down regulated in adenoma) gene is mu-
tated in congenital chloride diarrhea patients where
the basic defect has been shown to be an impaired
Cl3/HCO33 (OH
3) exchange process in the human
ileum and colon [29^33]. Although recent functional
studies have shown that DRA is able to transport
chloride [34,35], DRA was initially shown to be a
sulfate/oxalate transporter, which shares high homol-
ogy with a number of sulfate transporters but not
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with any member of the AE gene family [36]. More-
over, previous studies, utilizing colonic puri¢ed api-
cal membrane vesicles, have suggested that sulfate
and chloride transport are mediated via distinct
transporters [11]. Additional studies are required to
clearly identify the apical membrane Cl3/HCO33
(OH3) exchanger and delineate whether it is DRA
or a novel AE isoform.
In summary, our current results demonstrate that
AE2 and bAE3, but not AE1 and cAE3 are
expressed along the entire length of the human intes-
tine. The AE2 mRNA was expressed throughout the
surface^crypt axis. Furthermore, the polypeptide
products for AE2 and bAE3 were found to be local-
ized to the basolateral but not the apical membranes
of the epithelial cells of the human intestine and
their. These results suggest that human intestinal
AE2 and bAE3 isoforms are di¡erentially expressed
and may play an important role in vital cellular
functions, e.g. cell pH and volume regulation and
maintenance of intracellular Cl3 concentrations.
Further studies are needed to de¢ne the functions
of the AE2 and bAE3 isoforms and their regulation
in the human intestinal epithelial cells in normal con-
ditions, and to identify the potential apical mem-
brane isoform involved in luminal chloride absorp-
tion.
Acknowledgements
These studies were supported by Department of
Veterans A¡airs and National Institute of Diabetes
and Digestive and Kidney Diseases Grant DK33349,
and DK54016.
References
[1] R. Knickelbein, P.S. Aronson, C.M. Schron, J. Seifter, J.W.
Dobbins, Am. J. Physiol. 249 (1985) G236^G245.
[2] S.L. Alper, Cell Physiol. Biochem. 4 (1994) 265^281.
[3] R.L. Lubman, S.I. Danto, D.C. Chao, C.E. Fricks, E.D.
Crandall, Am. J. Respir. Cell. Mol. Biol. 12 (1995) 211^219.
[4] A.E. Lindsey, K. Schneider, D.M. Simmons, R. Baron, B.S.
Lee, R.R. Kopito, Proc. Natl. Acad. Sci. USA 87 (1990)
5278^5282.
[5] S.L. Alper, H. Rossmann, S. Wilhelm, A.K. Stuart-Tilley,
B.E. Shmukler, U. Seidler, Am. J. Pshyiol. 277 (1999) G321^
G332.
[6] A. Stuart-Tilley, C. Sardet, J. Pouyssegur, M.A. Schwartz,
D. Brown, S.L. Alper, Am. J. Physiol. (1994) C559^C568.
[7] A. Chow, J.W. Dobbins, P.S. Aronson, P. Igarashi, Am.
J. Physiol. 263 (1992) G345^G352.
[8] H. Rossmann, M. Nader, U. Seidler, M. Classen, S. Alper,
Gastroenterology 108 (1995) A319.
[9] D. Yannoukakos, A.S. Tilley, H.A. Fernandez, P. Fey, G.
Duyk, S.L. Alper, Circ. Res. 75 (1994) 603^614.
[10] P.K. Dudeja, J.M. Harig, K. Ramaswamy, M. Prell, T.A.
Brasitus, Gastroenterology 102 (1992) A208.
[11] R.J. Mahajan, M.L. Baldwin, J.M. Harig, K. Ramaswamy,
P.K. Dudeja, Biochim. Biophys. Acta 1280 (1996) 12^18.
[12] S. Tyagi, K. Ramaswamy, P.K. Dudeja, Gastroenterology
110 (1996) A369.
[13] P. Chomczynski, N. Sacchi, Anal. Biochem. 162 (1987) 156.
[14] S.E. Lux, K.M. John, R.R. Kopito, H.F. Lodish, Proc. Natl.
Acad. Sci. USA 86 (1989) 9089^9093.
[15] J. Medina, A. Acin, J. Prieto, Genomics 39 (1997) 74^85.
[16] P.K. Dudeja, D.D. Rao, I. Syed, V. Joshi, R.Y. Dahdal, C.
Gardner, M.C. Risk, L. Schmidt, D. Bavishi, K.E. Kim,
J.M. Harig, J.L. Goldstein, T.J. Layden, K. Ramaswamy,
Am. J. Physiol. 271 (1996) G483^G493.
[17] G.J. Nuovo, 3rd edn., Lippincott-Raven Publishers, Phila-
delphia, 1996.
[18] J.M. Harig, P.K. Dudeja, S.M. Knaup, J. Shoshara, K.
Ramaswamy, T.A. Brasitus, Biochem. Biophys. Res. Com-
mun. 167 (1990) 438^443.
[19] V.M. Rajendran, J.M. Harig, M.B. Adams, K. Ramaswamy,
Am. J. Physiol. 252 (1987) G33^G39.
[20] Z. Zamir, J.A. Barry, K. Ramaswamy, Gastroenterology 103
(1992) 1817^1822.
[21] P.K. Dudeja, M.L. Baldwin, J.M. Harig, Gastroenterology
104 (1993) A245.
[22] S. Tyagi, V. Joshi, W.A. Alrefai, R.A. Gill, K. Ramaswamy,
P.K. Dudeja, Digestive Diseases and Sciences, 2000 (in
press).
[23] H. Gehrig, W. Muller, H. Appelhans, Biochim. Biophys.
Acta 1130 (1992) 326^328.
[24] K. Ramaswamy, J.M. Harig, J.G. Kleinman, M.S. Harris,
N.Y. Acad. Sci. 574 (1989) 128^130.
[25] V.M. Rajendran, P. Sangan, J. Black, H.J. Binder, Gastro-
enterology 112 (1997) A396.
[26] R.R. Kopito, B.S. Lee, D.M. Simmons, A.E. Lindsey, C.W.
Morgans, K. Schneider, Cell 59 (1989) 927^937.
[27] V. Rajendran, P. Sangan, A. Mann, M. Kashgarian, S.
Alper, J. Black, H. Binder, Gastroenterology 114 (1998)
A408.
[28] S.T. Alper, A.K. Stuart-Tilley, D. Biemesderfer, B.E.
Shmukler, D. Brown, Am. J. Physiol. 273 (1997) F601^F614.
[29] R. Norio, J. Perheentupa, K. Launiala, N. Hallman, Clin.
Genet. 2 (1971) 182^192.
[30] F.A. Bieberdorf, P. Gordon, J.S. Fordtran, J. Clin. Invest.
51 (1972) 1958^1968.
BBAMEM 78025 1-3-01 Cyaan Magenta Geel Zwart
W.A. Alrefai et al. / Biochimica et Biophysica Acta 1511 (2001) 17^2726
[31] J. Kere, P. Sistonen, C. Holmberg, A. Chapelle, Proc. Natl.
Acad. Sci. USA 90 (1993) 10686^10689.
[32] P. Hoglund, S. Haila, J. Socha, L. Tomaszewski, U. Saar-
ialho-kere, M.L.K. Lindsberg, A. Chapelle, J. Kere, Nat.
Genet. 14 (1996) 316^319.
[33] J. Kere, H. Lohi, P. Hoglund, Am. J. Physiol. 276 (1999)
G7^G13.
[34] D.G. Silberg, W. Wang, R.H. Moseley, P.G. Traber, J. Biol.
Chem. 270 (1995) 11897^11902.
[35] J.E. Melvin, K. Park, L. Richardson, P.J. Shultheis, G.E.
Shull, J. Biol. Chem. 274 (1999) 22855^22861.
[36] R.H. Moseley, P. Hoglund, G.D. Wu, D.G. Silberg, S. Hai-
la, A.D.L. Chapelle, C. Holmberg, J. Fere, Am. J. Physiol.
267 (1999) G185^G192.
BBAMEM 78025 1-3-01 Cyaan Magenta Geel Zwart
W.A. Alrefai et al. / Biochimica et Biophysica Acta 1511 (2001) 17^27 27
